Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Dietary whey protein lessens several risk factors for metabolic diseases: a review|
|Author:||Sousa, Gabriela T. D.|
Lira, Fabio S.
Rosa, Jose C.
de Oliveira, Erick P.
Oyama, Lila M.
Santos, Ronaldo V.
Pimentel, Gustavo D.
|Abstract:||Obesity and type 2 diabetes mellitus (DM) have grown in prevalence around the world, and recently, related diseases have been considered epidemic. Given the high cost of treatment of obesity/DM-associated diseases, strategies such as dietary manipulation have been widely studied; among them, the whey protein diet has reached popularity because it has been suggested as a strategy for the prevention and treatment of obesity and DM in both humans and animals. Among its main actions, the following activities stand out: reduction of serum glucose in healthy individuals, impaired glucose tolerance in DM and obese patients; reduction in body weight; maintenance of muscle mass; increases in the release of anorectic hormones such as cholecystokinin, leptin, and glucagon like-peptide 1 (GLP-1); and a decrease in the orexigenic hormone ghrelin. Furthermore, studies have shown that whey protein can also lead to reductions in blood pressure, inflammation, and oxidative stress.|
Type 2 diabetes mellitus
|Editor:||Biomed Central Ltd|
|Citation:||Lipids In Health and Disease. Biomed Central Ltd, v.11, 2012|
|Appears in Collections:||FCM - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.